Clin Mol Hepatol.
2020 Oct;26(4):476-479. 10.3350/cmh.2020.0192.
Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
- Affiliations
-
- 1Chaum Life Center, Department of Internal Medicine, CHA University School of Medicine, Seoul, Korea
- 2Division of Gastroenterology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
- KMID: 2507964
- DOI: http://doi.org/10.3350/cmh.2020.0192
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Personalized management of cirrhosis by non-invasive tests of liver fibrosis
- Clinical Significance of Sarcopenia in Patients with Advanced Hepatocellular Carcinoma Undergoing Sorafenib Treatment
- Clinical application of liver stiffness measurement for assessing the risk of hepatocellular carcinoma
- Preoperative Evaluation and Postoperative Complications with Prognostic Impact of Surgical Resection for the Hepatocellular Carcinoma in Cirrhotics
- 3 Cases of Portal Vein Thrombosis in Hepatocellular Carcinoma and Liver Cirrhosis Treated with Anticoagulation
